---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-036566"
form_type: "8-K"
ticker: "JBIO"
cik: "0001798749"
company_name: "Jade Biosciences, Inc."
filed_at: "2025-04-21T23:59:59+00:00"
generated_at: "2026-05-23T10:31:18.786947+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Aerovate stockholders approve merger with Jade Biosciences, 1-for-35 reverse split

## Summary
- All eight proposals approved at April 16 special meeting, including merger and reverse stock split.
- Board approves 1-for-35 reverse split, reducing outstanding from ~30M to ~0.8M shares.
- Special cash dividend of $69.6M ($2.40/share) unaffected; record date April 25.
- Combined company to trade as JBIO on Nasdaq starting April 29 after merger close.

## SEC filing metadata
- accession: 0001104659-25-036566
- form_type: 8-K
- ticker: JBIO
- cik: 0001798749
- company_name: Jade Biosciences, Inc.
- filed_at: 2025-04-21T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.07, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1798749/000110465925036566/0001104659-25-036566-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1798749/000110465925036566/tm2512432d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-036566
- JSON: https://secwatch.observer/filing/0001104659-25-036566.json
- Plain text: https://secwatch.observer/filing/0001104659-25-036566.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.